143 related articles for article (PubMed ID: 38059357)
1. Diagnostic utility of the 23-gene expression profile test for an atypical intradermal melanocytic proliferation.
Marks E; Badia AA; Goldberg MS
Per Med; 2024 Jan; 21(1):21-27. PubMed ID: 38059357
[TBL] [Abstract][Full Text] [Related]
2. PRAME expression in melanocytic proliferations with intermediate histopathologic or spitzoid features.
Raghavan SS; Wang JY; Kwok S; Rieger KE; Novoa RA; Brown RA
J Cutan Pathol; 2020 Dec; 47(12):1123-1131. PubMed ID: 32700786
[TBL] [Abstract][Full Text] [Related]
3. PRAME immunohistochemistry of spitzoid neoplasms.
Koh SS; Lau SK; Scapa JV; Cassarino DS
J Cutan Pathol; 2022 Aug; 49(8):709-716. PubMed ID: 35488519
[TBL] [Abstract][Full Text] [Related]
4. A Comparison of Preferentially Expressed Antigen in Melanoma Immunohistochemistry and Diagnostic Gene Expression-Profiling Assay in Challenging Melanocytic Proliferations.
Casillas AC; Muhlbauer A; Barragan VA; Jefferson I; Speiser JJ
Am J Dermatopathol; 2024 Mar; 46(3):137-146. PubMed ID: 38354382
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Immunohistochemistry for PRAME With Cytogenetic Test Results in the Evaluation of Challenging Melanocytic Tumors.
Lezcano C; Jungbluth AA; Busam KJ
Am J Surg Pathol; 2020 Jul; 44(7):893-900. PubMed ID: 32317605
[TBL] [Abstract][Full Text] [Related]
6. The utility of PRAME immunohistochemistry in the evaluation of challenging melanocytic tumors.
Alomari AK; Tharp AW; Umphress B; Kowal RP
J Cutan Pathol; 2021 Sep; 48(9):1115-1123. PubMed ID: 33660310
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic utility of PRAME in distinguishing proliferative nodules from melanoma in giant congenital melanocytic nevi.
Gill P; Prieto VG; Austin MT; Giubellino A; Torres-Cabala CA
J Cutan Pathol; 2021 Nov; 48(11):1410-1415. PubMed ID: 34164835
[TBL] [Abstract][Full Text] [Related]
8. Proliferation indices correlate with diagnosis and metastasis in diagnostically challenging melanocytic tumors.
Al-Rohil RN; Curry JL; Torres-Cabala CA; Nagarajan P; Ivan D; Aung PP; Lyons GF; Bassett RL; Prieto VG; Tetzlaff MT
Hum Pathol; 2016 Jul; 53():73-81. PubMed ID: 27004944
[TBL] [Abstract][Full Text] [Related]
9. Role of In Vivo Reflectance Confocal Microscopy in the Analysis of Melanocytic Lesions.
Serban ED; Farnetani F; Pellacani G; Constantin MM
Acta Dermatovenerol Croat; 2018 Apr; 26(1):64-67. PubMed ID: 29782304
[TBL] [Abstract][Full Text] [Related]
10. Preferentially expressed Antigen in MElanoma immunohistochemistry as an adjunct for evaluating ambiguous melanocytic proliferation.
Fattori A; de la Fouchardière A; Cribier B; Mitcov M
Hum Pathol; 2022 Mar; 121():19-28. PubMed ID: 34990622
[TBL] [Abstract][Full Text] [Related]
11. Pitfalls of PRAME Immunohistochemistry in a Large Series of Melanocytic and Nonmelanocytic Lesions With Literature Review.
Turner N; Ko CJ; McNiff JM; Galan A
Am J Dermatopathol; 2024 Jan; 46(1):21-30. PubMed ID: 37982498
[TBL] [Abstract][Full Text] [Related]
12. Preferentially Expressed Antigen in Melanoma Immunostaining in a Series of Melanocytic Neoplasms.
Googe PB; Flanigan KL; Miedema JR
Am J Dermatopathol; 2021 Nov; 43(11):794-800. PubMed ID: 33989214
[TBL] [Abstract][Full Text] [Related]
13. Genomic aberrations in spitzoid melanocytic tumours and their implications for diagnosis, prognosis and therapy.
Wiesner T; Kutzner H; Cerroni L; Mihm MC; Busam KJ; Murali R
Pathology; 2016 Feb; 48(2):113-31. PubMed ID: 27020384
[TBL] [Abstract][Full Text] [Related]
14. Atypical Spitz Tumors: A Diagnostic Challenge.
Harms KL; Lowe L; Fullen DR; Harms PW
Arch Pathol Lab Med; 2015 Oct; 139(10):1263-70. PubMed ID: 26414472
[TBL] [Abstract][Full Text] [Related]
15. Fluorescence in situ hybridization, a diagnostic aid in ambiguous melanocytic tumors: European study of 113 cases.
Vergier B; Prochazkova-Carlotti M; de la Fouchardière A; Cerroni L; Massi D; De Giorgi V; Bailly C; Wesselmann U; Karlseladze A; Avril MF; Jouary T; Merlio JP
Mod Pathol; 2011 May; 24(5):613-23. PubMed ID: 21151100
[TBL] [Abstract][Full Text] [Related]
16. A Diagnostic Algorithm Combining Immunohistochemistry and Molecular Cytogenetics to Diagnose Challenging Melanocytic Tumors.
Redon S; Guibourg B; Talagas M; Marcorelles P; Uguen A
Appl Immunohistochem Mol Morphol; 2018; 26(10):714-720. PubMed ID: 28362709
[TBL] [Abstract][Full Text] [Related]
17. Ciliation Index Is a Useful Diagnostic Tool in Challenging Spitzoid Melanocytic Neoplasms.
Lang UE; Torres R; Cheung C; Vladar EK; McCalmont TH; Kim J; Judson-Torres RL
J Invest Dermatol; 2020 Jul; 140(7):1401-1409.e2. PubMed ID: 31978411
[TBL] [Abstract][Full Text] [Related]
18. Observational Study Examining the Diagnostic Practice of Ki67 Staining for Melanocytic Lesions.
Vyas NS; Charifa A; Desman GT; Goldberg M; Singh R; Phelps RG; McNiff JM
Am J Dermatopathol; 2019 Jul; 41(7):488-491. PubMed ID: 31233404
[TBL] [Abstract][Full Text] [Related]
19. Melanoma Developing from an Intradermal Nevus: Report on Two Patients.
Ledić Drvar D; Radoš J; Manola I; Mataić A; Dotlić S; Krušlin B
Acta Dermatovenerol Croat; 2023 Aug; 31(1):40-42. PubMed ID: 37843090
[TBL] [Abstract][Full Text] [Related]
20. PRAME expression in cutaneous melanoma does not correlate with disease-specific survival.
Parra O; Ma W; Li Z; Coffing BN; Linos K; LeBlanc RE; Momtahen S; Sriharan A; Cloutier JM; Wells WA; Yan S
J Cutan Pathol; 2023 Oct; 50(10):903-912. PubMed ID: 37430414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
